A study has found that a DNA vaccine tested in mice reduces accumulation of both toxic proteins associated with Alzheimer's disease (beta-amyloid and tau).
Research from the Systolic Blood Pressure Intervention Trial (SPRINT) shows that treatment to lower blood pressure can reduce Mild Cognitive Impairment (MCI).
New research into the cognitive effects of hormone replacement therapy has been presented at Alzheimer’s Association International Conference (AAIC) in Chicago.
There are many things that increase a person’s chances of developing vascular dementia. These are called ‘risk factors’. It is possible to avoid some risk factors, while others cannot be controlled.
From the December 2015/January 2016 issue of our magazine, The Society has two new factsheets for people with learning disabilities. Andrew Bence meets the people who helped to develop and test them.